Go to Page # Page of 21
loading

Discovery of Cardioprotective Prokineticin Receptor Agonist: Anti-Cancer Drug Induced Cardiotoxicity

 Canan Nebigil
  31st-Dec-2018
Description: Dexrazoxane is the only FDA & EMA approved cardioprotective agent to prevent anticancer drug-induced cardiotoxicity Prokineticin/PKR1 is ideal candidate to regenerate damaged heart.
Views: 4838
Domain: Medical
Category: Biology
weSRCH App on Apple
Contents:
Discovery of cardioprotective
prokineticin receptor agonist: anti-cancer
drug induced cardiotoxicity
Canan Nebigil, DR2, CNRS
nebigil@unistra.fr
UMR7242, ESBS
AnP, 30 May, 2018

Most of the anticancer treatments
induce cardiotoxicity
Antracyclines

Radiation

Cardiotoxicity
HER-2
inhibitors
VEGF
inhibitors

Cisplatin
Vinca
alkaloids
bleomycin

Cardiovascular side effects of anti-cancer
treatment ... See more

Recent Presentations

ASPR Tracie Resources Overview 2019

The healthcare supply chain is confronted with many small to large daily challenges & under distinct strains during disasters. while HCC supply chain integrity self-assessment.

...
22 September, 2019
...
21 September, 2019
Yoojin Oh
20 September, 2019